Dose-sparing and safety-enhancing effects of an IGF-I-based dosing regimen in short children treated with growth hormone in a 2-year randomized controlled trial: therapeutic and pharmacoeconomic considerations
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dose-sparing and safety-enhancing effects of an IGF-I-based dosing regimen in short children treated with growth hormone in a 2-year randomized controlled trial: therapeutic and pharmacoeconomic considerations
Authors
Keywords
-
Journal
CLINICAL ENDOCRINOLOGY
Volume 81, Issue 1, Pages 71-76
Publisher
Wiley
Online
2014-01-16
DOI
10.1111/cen.12408
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recombinant human growth hormone for the treatment of growth disorders in children: a systematic review and economic evaluation
- (2014) A Takeda et al. HEALTH TECHNOLOGY ASSESSMENT
- Serum insulin-like growth factor 1 correlates with the risk of nodal metastasis in endocrine-positive breast cancer
- (2013) F. Morgillo et al. Current Oncology
- Efficacy of IGF-based growth hormone (GH) dosing in nonGH-deficient (nonGHD) short stature children with low IGF-I is not related to basal IGF-I levels
- (2012) Pinchas Cohen et al. CLINICAL ENDOCRINOLOGY
- Long-Term Therapy with Growth Hormone: Bringing Sagacity to SAGHE
- (2012) Mark A. Sperling JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Long-Term Mortality after Recombinant Growth Hormone Treatment for Isolated Growth Hormone Deficiency or Childhood Short Stature: Preliminary Report of the French SAGhE Study
- (2012) Jean-Claude Carel et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Long-Term Mortality and Causes of Death in Isolated GHD, ISS, and SGA Patients Treated with Recombinant Growth Hormone during Childhood in Belgium, The Netherlands, and Sweden: Preliminary Report of 3 Countries Participating in the EU SAGhE Study
- (2012) Lars Sävendahl et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Prediction models for short children born small for gestational age (SGA) covering the total growth phase. Analyses based on data from KIGS (Pfizer International Growth Database)
- (2011) Michael B Ranke et al. BMC Medical Informatics and Decision Making
- Consensus Statement on the Standardization and Evaluation of Growth Hormone and Insulin-like Growth Factor Assays
- (2011) D. R. Clemmons et al. CLINICAL CHEMISTRY
- Minireview: IGF, Insulin, and Cancer
- (2011) Emily J. Gallagher et al. ENDOCRINOLOGY
- Evolution of IGF-1 in Children Born Small for Gestational Age and with Growth Retardation, Treated by Growth Hormone Adapted to IGF-1 Levels after 1 Year
- (2011) S. Cabrol et al. Hormone Research in Paediatrics
- How useful are serum IGF-I measurements for managing GH replacement therapy in adults and children?
- (2011) Anna Pawlikowska-Haddal et al. Pituitary
- Elevated Insulin-Like Growth Factor-I Values in Children with Prader-Willi Syndrome Compared with Growth Hormone (GH) Deficiency Children over Two Years of GH Treatment
- (2010) Eva Feigerlová et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Variable Degree of Growth Hormone (GH) and Insulin-Like Growth Factor (IGF) Sensitivity in Children with Idiopathic Short Stature Compared with GH-Deficient Patients: Evidence from an IGF-Based Dosing Study of Short Children
- (2010) Pinchas Cohen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Observed and Predicted Growth Responses in Prepubertal Children with Growth Disorders: Guidance of Growth Hormone Treatment by Empirical Variables
- (2010) Michael B. Ranke et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Growth hormone, the insulin-like growth factor axis, insulin and cancer risk
- (2010) Peter E. Clayton et al. Nature Reviews Endocrinology
- The cost-effectiveness of somatropin treatment for short children born small for gestational age (SGA) and children with growth hormone deficiency (GHD) in Sweden
- (2010) Torsten Christensen et al. JOURNAL OF MEDICAL ECONOMICS
- Long-Term Safety of Recombinant Human Growth Hormone in Children
- (2009) J. Bell et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD)
- (2008) K. Chihara et al. GROWTH HORMONE & IGF RESEARCH
- Circulating insulin-like growth factor peptides and prostate cancer risk: A systematic review and meta-analysis
- (2008) Mari-Anne Rowlands et al. INTERNATIONAL JOURNAL OF CANCER
- Consensus Statement on the Diagnosis and Treatment of Children with Idiopathic Short Stature: A Summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop
- (2008) P. Cohen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Growth Hormone (GH) Dosing during Catch-Up Growth Guided by Individual Responsiveness Decreases Growth Response Variability in Prepubertal Children with GH Deficiency or Idiopathic Short Stature
- (2008) Berit Kriström et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Height Velocity Targets from the National Cooperative Growth Study for First-Year Growth Hormone Responses in Short Children
- (2007) Bert Bakker et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started